MTOR and hepatocellular carcinoma: In a next step, we analyzed the effects of a combined treatment with AKT and mTOR inhibitors on the CD90+ HCC-related cell line SK-HEP1 which successfully formed tumoroids under ultralow attachment conditions (Figure 4A).